首页 › 期刊 › 医学 › MMWR Morbidity and Mortality Weekly Report
MMWR Morbidity and Mortality Weekly Report
出版商:Centers for Disease Control MMWR Office · ISSN:0149-2195, 1545-861X, 1546-0738, 1545-8636, 1057-5987, 1545-8601, 0892-3787 · 国家/地区:US · 类型:journal · OA 开放获取 · 官网:http://www.cdc.gov/mmwr/
研究主题:Vaccine Coverage and Hesitancy · SARS-CoV-2 and COVID-19 Research · COVID-19 epidemiological studies · Respiratory viral infections research · Viral gastroenteritis research and epidemiology
核心指标
- 影响因子(JCR 2024):60.100
- JCR 分区:Q1(PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH(SCIE))
- 中科院分区(2025):医学 1区(Top);小类:PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生 1区
- 新锐分区(2026):医学 1区
- SJR:27,974(Q1)
- h-index:252
- i10 指数:2521
- 近两年篇均被引:17.37
- 载文量 4094 · 总被引 291280
逐年趋势
- 近年影响因子:2020 55.9 → 2021 36.3 → 2022 33.7 → 2024 60.1
- 近年 SJR:2021 25(Q1) → 2022 24(Q1) → 2023 14.6(Q1) → 2024 41.8(Q1) → 2025 28(Q1)
同学科期刊推荐
- CA-A CANCER JOURNAL FOR CLINICIANS — IF 685.2 · JCR Q1 · 中科院1区(Top)
- The Lancet — IF 109.0 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Clinical Oncology — IF 94.6 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Drug Discovery — IF 91.2 · JCR Q1 · 中科院1区(Top)
- Kidney International Supplements — IF 89.6 · JCR Q1 · 中科院2区
- New England Journal of Medicine — IF 84.5 · JCR Q1 · 中科院1区(Top)
- Annals of Oncology — IF 80.4 · JCR Q1 · 中科院1区(Top)
- World Psychiatry — IF 65.8 · JCR Q1 · 中科院1区(Top)
常见问题
《MMWR Morbidity and Mortality Weekly Report》的影响因子是多少?
根据 JCR 2024 年数据,《MMWR Morbidity and Mortality Weekly Report》的最新影响因子(IF)为 60.100。
《MMWR Morbidity and Mortality Weekly Report》是几区期刊?
《MMWR Morbidity and Mortality Weekly Report》中科院分区(2025年版)为医学1区(Top 期刊),JCR 分区为 Q1。
《MMWR Morbidity and Mortality Weekly Report》是开放获取(OA)期刊吗?
是,《MMWR Morbidity and Mortality Weekly Report》是开放获取(Open Access)期刊。
本刊近期代表论文
- Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025 (2025 · 被引 85)
- Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness — Four Vaccine Effectiveness Networks, United States, October 2024–February 2025 (2025 · 被引 62)
- Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus–Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025 (2025 · 被引 43)
- Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis — United States, 2025 (2025 · 被引 16)
- Outbreak of Neisseria meningitidis Conjunctivitis in Military Trainees — Texas, February–May 2025 (2025 · 被引 1)
- Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases — United States, 2024 (2024 · 被引 130)